LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 1 | 27.49 | 27.76 | 692 | 1723 | 0.4016 | 0.7160 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 27.49 | 27.76 | 1 | 1723 | 0.0006 | -0.4277 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 27.49 | 27.76 | 619 | 1723 | 0.3592 | 0.6841 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 29.19 | 27.76 | 25 | 1863 | 0.0134 | -0.0171 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 29.19 | 27.76 | 719 | 1863 | 0.3859 | 0.7096 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 29.19 | 27.76 | 1 | 1863 | 0.0005 | -0.4217 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 29.19 | 27.76 | 646 | 1863 | 0.3467 | 0.6797 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 30.90 | 27.76 | 29 | 2032 | 0.0143 | 0.0071 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 30.90 | 27.76 | 679 | 2032 | 0.3341 | 0.6756 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 30.90 | 27.76 | 1 | 2032 | 0.0005 | -0.4153 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 30.90 | 27.76 | 695 | 2032 | 0.3420 | 0.6819 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 32.60 | 27.76 | 33 | 2235 | 0.0148 | 0.0277 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 32.60 | 27.76 | 661 | 2235 | 0.2956 | 0.6499 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 32.60 | 27.76 | 1 | 2235 | 0.0004 | -0.4084 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 32.60 | 27.76 | 693 | 2235 | 0.3100 | 0.6622 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 34.30 | 27.76 | 39 | 2449 | 0.0159 | 0.0540 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 34.30 | 27.76 | 704 | 2449 | 0.2874 | 0.6491 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 34.30 | 27.76 | 1 | 2449 | 0.0004 | -0.4020 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 34.30 | 27.76 | 682 | 2449 | 0.2784 | 0.6410 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 36.01 | 27.76 | 41 | 2662 | 0.0154 | 0.0610 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 36.01 | 27.76 | 710 | 2662 | 0.2666 | 0.6362 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 36.01 | 27.76 | 1 | 2662 | 0.0004 | -0.3964 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 36.01 | 27.76 | 722 | 2662 | 0.2711 | 0.6404 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 37.71 | 27.76 | 46 | 2877 | 0.0160 | 0.0784 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 37.71 | 27.76 | 691 | 2877 | 0.2401 | 0.6162 | MN20160318_Q01 | E14 |